wlt_thumbnail-611
Yegna Manojavam Drugs & Chemicals Ltd., is a professionally managed GMP manufacturer of Active Pharmaceuticals and Intermediate chemicals located at Hyderabad, A.P. India. We are established in 20
City Hyderabad
Phone +91 86942 00541
Website Visit Link Here
Contact Person Name Dr. RLYP Sastry
Country India
State/Province Telangana
distance: 2 Kilometers

Yegna Manojavam Drugs & Chemicals Ltd., is a professionally managed GMP manufacturer of Active Pharmaceuticals and Intermediate chemicals located at Hyderabad, A.P. India.

We are established in 2004 with the manufacturing facility located in an 8+ acre plot on the outskirts of Hyderabad, India.

The current built up area is 5000 sq. mtrs with 55 Stainless and Glass Lined Reactors producing in excess of 800 Tons Per Year of APIs and Intermediate chemicals. Total reaction capabilities are in excess of 250 KL.

We are one of the largest, vertically-integrated manufacturers in India for Quinolones and Ciprofloxacin, Enrofloxacin and Norfloxacin currently.

As a vertically integrated company, we manufacture all the key intermediates to ensure consistently high quality, cost effectively.

Regulatory Status
We are currently GMP ( India certified ) . As a large volume production facility and as part of our expansion plans we are increasing our production blocks and clean rooms and moving towards cGMP, USFDA and EGMP certifications in 2011.

Vision & Values
We will strive to become the preferred partner for our customers globally and attain leadership in our product categories through continuous learning and innovative practices.

We are committed to ensure our products meet the highest quality global standards and above all, are manufactured with utmost concern for the environment.

Mission
We will achieve our vision globally through a dedicated customer-centric focus.

We will maintain leadership through a program of continuous learning and deliver high quality products and services competitively, on time and thereby create value for all our customers and stake holders.

Strength
Our key strengths are our strong technological base, qualified and trained people and well equipped Quality Control and R&D laboratories.

YM has gained expertise in handling very large volumes of Sodium Hydride reactions over the past few years. Our plant has a separate Sodium Hydride block using kerosene circulation to ensure safe handling of sodium based reactions.

We are vertically integrated with current manufacturing volumes in excess of 75 MT / month of key Qunilone Intermediates and APIs – Ciprofloxacin, Enrofloxacin and Norfloxacin.

Further capacity expansions are planned for 2011 and new Therapeutic Categories are being added.

As part of our holistic quality philosophy, we are committed to ensuring cGmp compliance in all areas of our operations through our qualitifed and trained teams

CGMP lays emphasis on QA. As a part of this YM Drugs has a core team identifying the various areas towards building quality and straining every nerve towards achieving its long-term goal of international cGMP compliance.

YM Drugs has Technical support from reputed Research Institutes such as Indian Institute of Chemical Technology (IICT) Hyderabad, and Jawaharlal Nehru Technological University (JNTU), Hyderabad.

Send Enquiry Submit your requirements to get a quote.


Business Details


Address

1-2-59/1, M-14/1
Street No. 3
Kakatiya Nagar, Habsiguda

City Hyderabad
State / Province / Region Telangana State
Country IN
Zip / Postal Code 500007
Phone +91 86942 00541
Other Phone / Mobile +91 85008 45546
Website Visit Link Here
Contact Person Name Dr. RLYP Sastry
Key Persons / Management

Dr. RLYP Sastry - Managing Director

Factory / Facilities

S.Y. No. 506 & 507, D. Nagaram (V),
Koyyalagudem (G.P) , Choutuppal (M)
Nalgonda Dist, Telangana.

Country India
State/Province Telangana
distance: 2 Kilometers
Address Habsiguda, Hyderabad, Telangana, India
Category , , ,
Subscribe ToBulkdrugs Directory Newsletter

Subscribe ToBulkdrugs Directory Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!